Association between Sirtuin 1 Gene rs10997870 polymorphism and suicide behaviors in bipolar disorder

Neuropsychobiology

Volumn 74, Issue 1, 2016, Pages 1-7

  Nivoli, Alessandra ^a   Porcelli, Stefano ^b   Albani, Diego ^c   Forloni, Gianluigi ^c   Fusco, Federica ^c   Colom, Francesc ^a   Vieta, Eduard ^a   Serretti, Alessandro ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Bipolar disorder; rs10997870 polymorphism; SIRT1 gene variant; Suicidal behavior

Indexed keywords

GENOMIC DNA; GUANINE; SIRTUIN 1; SIRT1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DNA DETERMINATION; DSM-IV; EXPLORATORY RESEARCH; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAMILTON DEPRESSION RATING SCALE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR MECHANICS; NATURALISTIC INQUIRY; OUTPATIENT; PRIORITY JOURNAL; RESTLESSNESS; SIRTUIN 1 GENE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; GENETICS; MULTIVARIATE ANALYSIS; PSYCHOLOGY; STATISTICAL MODEL; SUICIDE ATTEMPT;

ADULT; ALLELES; BIPOLAR DISORDER; COHORT STUDIES; DEPRESSION; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PSYCHOMOTOR AGITATION; SIRTUIN 1; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84978933093     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000446921     Document Type: Article

References (54)

1. Angst J, Angst F, Gerber-Werder R, Gamma A: Suicide in 406 mood-disorder patients with and without long-Term medication: a 40 to 44 years follow-up. Arch Suicide Res 2005; 9: 279-300.
2. Baldessarini RJ, Pompili M, Tondo L: Suicide in bipolar disorder: risks and management. CNS Spectr 2006; 11: 465-471.
3. Bondy B, Buettner A, Zill P: Genetics of suicide. Mol Psychiatry 2006; 11: 336-351.
4. Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S: Suicide and suicidal behavior. Epidemiol Rev 2008; 30: 133-154.
5. Grande IBM, Birmaher B, Vieta E: Bipolar disorder. Lancet, in press.
6. Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J: Nature and nurture in suicidal behavior, the role of genetics: some novel findings concerning personality traits and neural conduction. Physiol Behav 2007; 92: 245-249.
7. Calati R, Porcelli S, Giegling I, Hartmann AM, Moller HJ, De Ronchi D, et al: Catecholo-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-Analysis and association study. J Psychiatr Res 2011; 45: 309-321.
8. Brezo J, Klempan T, Turecki G: The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am 2008; 31: 179-203.
9. Jimenez E, Arias B, Mitjans M, Goikolea JM, Roda E, Saiz PA, et al: Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol 2013; 23: 1452-1462.
10. Giegling I, Chiesa A, Mandelli L, Gibiino S, Hartmann AM, Moller HJ, et al: Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits. Psychiatry Res 2010; 179: 222-225.
11. Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F, et al: Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res 2011; 45: 1106-1112.
12. Akbarian S: Approaching the molecular pathology of suicide. Biol Psychiatry 2008; 64: 643-644.
13. Bredy TW, Sun YE, Kobor MS: How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol 2010; 52: 331-342.
14. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, et al: Epigenetic status of GDNF in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011; 69: 359-372.
15. Bao J, Sack MN: Protein deacetylation by sirtuins: delineating a post-Translational regulatory program responsive to nutrient and redox stressors. Cell Mol Life Sci 2010; 67: 3073-3087.
16. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I: Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010; 501: 79-90.
17. Albani D, Polito L, Signorini A, Forloni G: Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2010; 36: 370-376.
18. Porcelli S, Salfi R, Politis A, Atti AR, Albani D, Chierchia A, et al: Association between sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. J Neural Transm 2013; 120: 1709-1715.
19. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al: SIRT1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007; 100: 1512-1521.
20. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, et al: A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466: 1105-1109.
21. Lee JY, Ahn K, Jang BG, Park SH, Kang HJ, Heo JI, et al: Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine-deficient phenotype. Neurosci Lett 2009; 461: 163-166.
22. Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, et al: SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disord 2010; 126: 167-173.
23. Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, et al: SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010; 30: 9695-9707.
24. Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, et al: SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 2011; 147: 1459-1472.
25. Webb RT, Lichtenstein P, Larsson H, Geddes JR, Fazel S: Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J Clin Psychiatry 2014; 75:e809-e816.
26. Costa L da S, Alencar AP, Nascimento Neto PJ, dos Santos M do S, da Silva CG, Pinheiro S de F, et al: Risk factors for suicide in bipolar disorder: a systematic review. J Affect Disord 2015; 170: 237-254.
27. Zai CC, Manchia M, Sonderby IE, Yilmaz Z, De Luca V, Tiwari AK, et al: Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders. World J Biol Psychiatry 2015; 16: 171-179.
28. Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, et al: Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. J Affect Disord 2015; 187: 183-187.
29. Goes FS: The importance of anxiety states in bipolar disorder. Curr Psychiatry Rep 2015; 17: 3.
30. CONVERGE Consortium: Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523: 588-591.
31. Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, et al: Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord 2011; 133: 443-449.
32. Popovic D, Torrent C, Goikolea JM, Cruz N, Sanchez-Moreno J, Gonzalez-Pinto A, et al: Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand 2014; 129: 366-374.
33. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revised. Washington, American Psychiatric Association, 2000.
34. Ramos-Brieva JA, Cordero Villafafila A: Validation of the Castillian version of the Hamilton Rating Scale for Depression (in Spanish). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1986; 14: 324-334.
35. Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J: Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 2006; 93: 13-17.
36. Carvalho AF, Quevedo J, McIntyre RS, Soeiro-de-Souza MG, Fountoulakis KN, Berk M, et al: Treatment implications of predominant polarity and the polarity index: a comprehensive review. Int J Neuropsychopharmacol 2014; 18:1-11 .
37. Vieta E: Pros and cons of specialised care in bipolar disorder: an international perspective. Br J Psychiatry 2013; 202: 170-171.
38. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279-284.
39. Carafa V, Nebbioso A, Altucci L: Sirtuins and disease: the road ahead. Front Pharmacol 2012; 3: 4.
40. Codocedo JF, Allard C, Godoy JA, Varela-Nallar L, Inestrosa NC: SIRT1 regulates dendritic development in hippocampal neurons. PLoS One 2012; 7:e47073.
41. Turecki G, Ernst C, Jollant F, Labonte B, Mechawar N: The neurodevelopmental origins of suicidal behavior. Trends Neurosci 2012; 35: 14-23.
42. Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, et al: Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 2012; 136: 350-358.
43. Westrin A, Ekman R, Traskman-Bendz L: Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur Neuropsychopharmacol 1999; 9: 205-211.
44. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, et al: Hypothalamus-pituitaryadrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005; 57: 336-342.
45. Ota KT, Duman RS: Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis 2013; 57: 28-37.
46. Mateus-Pinheiro A, Patricio P, Bessa JM, Sousa N, Pinto L: Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression. Mol Psychiatry 2013; 18: 748-750.
47. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Zhang H, Pavuluri MN: Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 645-651.
48. Schmidt HD, Duman RS: Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010; 35: 2378-2391.
49. Vieta E: The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr Scand 2014; 129: 323-327.
50. Goldstein TR, Ha W, Axelson DA, Goldstein BI, Liao F, Gill MK, et al: Predictors of prospectively examined suicide attempts among youth with bipolar disorder. Arch Gen Psychiatry 2012; 69: 1113-1122.
51. McIntyre RS, Muzina DJ, Kemp DE, Blank D, Woldeyohannes HO, Lofchy J, et al: Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 2008; 10: 66-72.
52. Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE: Clinical and neurocognitive markers of suicidality in young adults. J Psychiatr Res 2013; 47: 586-591.
53. Schumann G, Binder EB, Holte A, de Kloet ER, Oedegaard KJ, Robbins TW, et al: Stratified medicine for mental disorders. Eur Neuropsychopharmacol 2014; 24: 5-50.
54. Vieta E: Personalised medicine applied to mental health: precision psychiatry (in Spanish). Rev Psiquiatria Salud Mental 2015; 8: 117-118.